June 14, 2018 article Open access Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy Ophthalmology DOI: 10.1016/j.ophtha.2018.04.021 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 46 stored of 357 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Interpretable Machine Learning for Course Prediction in Central Serous Chorioretinopathy Using Baseline OCT from a Multicenter Cohort 2026 American Journal of Ophthalmology article Medicine Retinal Diseases and Treatments Open access 0 citations Long-Term Follow-Up of PLACE and SPECTRA Trials: Outcomes After Successful and Unsuccessful Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy 2026 American Journal of Ophthalmology article Medicine Retinal Diseases and Treatments Open access 0 citations Risk factors for the development of subretinal fluid in the fellow eyes of patients with chronic central serous chorioretinopathy 2026 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access 0 citations Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4 2026 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access 0 citations Exploring retinal and choroidal characteristics on multimodal imaging in resolved central serous chorioretinopathy 2026 Eye article Medicine Retinal Diseases and Treatments Open access 0 citations Choroidal vascular hyperpermeability patterns in central serous chorioretinopathy correlate with microperimetry: CERTAIN study report 4 2025 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access 3 citations International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI) 2025 Asia-Pacific Journal of Ophthalmology article Medicine Retinal Diseases and Treatments Open access 10 citations Outcome and safety of multiple photodynamic therapy sessions in chronic central serous chorioretinopathy 2025 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access 4 citations ULTRAWIDEFIELD INDOCYANINE GREEN ANGIOGRAPHIC CHANGES AFTER PHOTODYNAMIC THERAPY IN CENTRAL SEROUS CHORIORETINOPATHY 2025 Retina article Medicine Retinal Diseases and Treatments Open access 4 citations Pachychoroid disease: review and update 2024 Eye article Medicine Retinal Diseases and Treatments Open access 121 citations Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages 2024 Investigative Ophthalmology & Visual Science article Medicine Retinal Diseases and Treatments Open access 1 citations Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®) 2024 Ophthalmology and Therapy article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access 24 citations Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2 2024 Acta Ophthalmologica article Medicine Retinal Diseases and Treatments Open access 14 citations Central serous chorioretinopathy: An evidence-based treatment guideline 2024 Progress in Retinal and Eye Research article Medicine Retinal Diseases and Treatments Open access 129 citations Clinical Landscape of Central Serous Chorioretinopathy in Germany: Retina.net CSC Registry Report Number 1 2024 Ophthalmologica article Medicine Retinal Diseases and Treatments Open access 14 citations Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis 2023 Ophthalmology Retina article Biochemistry, Genetics and Molecular Biology Retinal Development and Disorders Open access 17 citations NOn-Pachychoroid PEripapillary Schisis (NOPPES) of the Retina: A New Phenotype and its Differential Diagnosis 2023 Asia-Pacific Journal of Ophthalmology article Medicine Retinal Diseases and Treatments Open access 2 citations BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY 2023 Retina article Medicine Retinal Diseases and Treatments Open access 17 citations SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY 2023 Retina article Medicine Retinal Diseases and Treatments Open access 13 citations OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy 2023 Diagnostics article Medicine Retinal Diseases and Treatments Open access 37 citations 1–20 of 46 Page 1 / 3 Next → References 0